Graft-versus-Host Disease of the eyes can be mild or severe. This presentation describes the causes and consequences GVHD in the eyes. It also describes and recommends numerous remedies for treating this condition.

COVID-19 and its variants present ongoing risks to the general population and added risks for cancer patients, people with weak immune systems, and transplant survivors. This presentation reviews the basics about COVID-19, prevention strategies, recent variants, available therapies, and vaccine responses and provides specific advice for cancer patients and survivors.

Sepa como Minimizar el Riesgo de Desarrollar un Cáncer Secundario después del Trasplante de Células Madre.

There are many kinds of insurance plans and coverages available in the United States. This presentation describes different plans in both the private market and government sector to guide patients through the maze of options. It also describes how different plans may complement one another and provide fuller coverage than any single plan on its own.

Graft-versus-Host Disease (GVHD) is a common condition after a bone marrow or stem cell transplant that uses cells from a donor (an allogeneic transplant). The donor cells are called the “graft” and the patient is called the “host”. When the donor’s immune cells (the graft) are transplanted in the patient’s body (the host) they often unleash an immune system attack against the patient’s organs and tissues which can be mild, moderate or severe.